Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Care Facilities

Cross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States. The company operates in three segments: Nurse and Allied Staffing, Physician Staffing, and Search. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, branch-based local nurses, and allied staffing; short-term staffing of registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and travel allied professionals on long-term contract assignments, as well as workforce solutions, including MSP, OWS, RPO, IRP, EMR, and consulting services. It serves public and private acute care and non-acute care hospitals, government facilities, public and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, retailers, and other healthcare providers under the Cross Country brand. The Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants under the Cross Country Locums brand as independent contractors on temporary assignments at various healthcare facilities, such as acute and non-acute care facilities, medical gr...
Website: crosscountryhealthcare.com



Growth: Bad revenue growth rate -20.6%, there is acceleration compared to average historical growth rates -25.7%. The revenue growth dynamics is unstable

Profitability: LTM EBITDA margin is negative, -1.4%. On average the margin is decreasing unsteadily. Gross margin is normal, +20.4%. In the last quarter the company beat the estimated EPS, +12.0%. The company was ahead of estimated EPS in 100% of quarters (showing a gain of +$0.17 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield 6.8% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 20.3% higher than minimum and 68.0% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 0.2x by EV / Sales multiple , the company can be 6.2% overvalued

Insiders: For the last 3 months insiders bought company shares on $0.0 mln (0.015% of cap.)

Key Financials (Download financials)

Ticker: CCRN
Share price, USD:  (0.0%)9.06
year average price 12.62  


year start price 18.15 2025-02-14

max close price 18.15 2025-02-14

min close price 7.53 2025-12-04

current price 9.06 2026-02-13
Common stocks: 32 524 000

Dividend Yield:  0.0%
EV / Sales: 0.2x
Margin (EBITDA LTM / Revenue): -1.4%
Fundamental value created in LTM:
Market Cap ($m): 295
Net Debt ($m): -97
EV (Enterprise Value): 198
Price to Book: 0.7x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2025-12-11seekingalpha.com

Cross Country Healthcare: The Failed Merger Is Disappointing, But Selling Here Would Be A Mistake

2025-12-04businesswire.com

Cross Country Healthcare Merger Agreement with Aya Healthcare Terminated

2025-11-12zacks.com

Cross Country Healthcare (CCRN) Lags Q3 Earnings and Revenue Estimates

2025-10-13zacks.com

KELYA or CCRN: Which Is the Better Value Stock Right Now?

2025-08-06fool.com

CCRN Earnings Drop 19%

2025-08-06zacks.com

Cross Country Healthcare (CCRN) Reports Q2 Loss, Misses Revenue Estimates

2025-06-30seekingalpha.com

Cross Country Healthcare: At This Price, The Pending Acquisition Is Worth Betting On (Rating Upgrade)

2025-03-05zacks.com

Cross Country Healthcare (CCRN) Misses Q4 Earnings Estimates

2025-02-28businesswire.com

Cross Country Healthcare Stockholders Approve Aya Healthcare Transaction

2025-02-19zacks.com

3 Staffing Stocks to Consider Despite Industry Challenges
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol CCRN CCRN CCRN CCRN CCRN CCRN CCRN CCRN CCRN CCRN CCRN CCRN CCRN CCRN
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-12 2025-08-06 2024-11-07 2024-08-01 2024-05-02 2023-11-02 2023-08-03 2023-05-04 2022-11-03
acceptedDate 2025-11-12 17:06:35 2025-08-06 16:45:15 2025-03-05 16:45:30 2024-11-07 15:59:06 2024-08-01 10:15:54 2024-05-02 07:12:10 2024-02-22 18:05:52 2023-11-02 09:41:38 2023-08-03 08:48:36 2023-05-04 09:02:53 2023-02-23 16:42:22 2022-11-03 11:11:20 2022-02-28 16:43:04 2021-02-25 16:17:22
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 250M 274M 1 344M 315M 340M 379M 2 020M 442M 541M 623M 2 803M 636M 1 677M 836M
costOfRevenue 199M 218M 1 070M 251M 274M 307M 1 569M 345M 418M 483M 2 179M 493M 1 302M 634M
grossProfit 51M 56M 274M 64M 66M 73M 450M 97M 123M 139M 624M 144M 375M 203M
grossProfitRatio 0.204 0.204 0.204 0.195 0.192 0.22 0.228 0.224 0.226
researchAndDevelopmentExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0
generalAndAdministrativeExpenses 0 0 246M 0 0 0 303M 0 0 0 0 0 211M 171M
sellingAndMarketingExpenses 0 0 9M 0 0 0 12M 0 0 0 0 0 10M 6M
sellingGeneralAndAdministrativeExpenses 0 50M 255M 54M 79M 65M 315M 70M 79M 84M 324M 80M 220M 177M
otherExpenses 57M 12M 36M 7M 212 000 1M 23M -134 000 339M 5M 30M 3M 16M 35M
operatingExpenses 57M 62M 291M 61M 79M 65M 338M 74M 418M 89M 355M 83M 236M 212M
costAndExpenses 256M 280M 1 361M 312M 353M 371M 1 907M 419M 418M 572M 2 534M 576M 1 537M 846M
interestIncome 864 000 702 000 2M 1M 0 0 0 669 000 0 0 10000 0 0 0
interestExpense 556 000 549 000 2M 550 000 568 000 462 000 8M 669 000 3M 4M 14M 3M 7M 3M
depreciationAndAmortization 4M 4M 17M 4M 5M 5M 18M 5M 4M 11M 13M 3M 9M 10M
ebitda -993 000 -1M 17M 8M -14M 13M 129M 28M 38M 55M 280M 55M 155M 26M
ebitdaratio -0.004 -0.004 0.027 -0.024 0.034 0.062 0.07 0.089 0.087
operatingIncome -6M -6M -17M 3M -13M 8M 113M 20M 35M 44M 270M 52M 139M -9M
operatingIncomeRatio -0.024 -0.021 0.009 -0.038 0.021 0.046 0.065 0.07 0.082
totalOtherIncomeExpensesNet 336 000 130 000 467 000 536 000 -356 000 -4M -10M -3M -5M -4M -17M -3M -6M -3M
incomeBeforeTax -6M -6M -16M 3M -20M 4M 103M 20M 30M 40M 253M 49M 133M -12M
incomeBeforeTaxRatio -0.023 -0.021 0.011 -0.058 0.01 0.044 0.056 0.064 0.077
incomeTaxExpense -863 000 930 000 -2M 834 000 -4M 997 000 30M 7M 9M 11M 67M 14M 1M -188 000
netIncome -5M -7M -15M 3M -16M 3M 73M 13M 21M 29M 186M 35M 132M -13M
netIncomeRatio -0.019 -0.024 0.008 -0.047 0.007 0.029 0.039 0.047 0.055
eps -0.15 -0.2 -0.44 0.077 -0.47 0.079 2.07 0.37 0.6 0.82 5.09 0.94 3.6 -0.34
epsdiluted -0.15 -0.2 0.077 -0.47 0.078 0.36 0.6 0.81 0.93
weightedAverageShsOut 33M 32M 33M 33M 34M 34M 35M 35M 35M 36M 37M 37M 37M 36M
weightedAverageShsOutDil 33M 32M 33M 33M 34M 35M 35M 35M 36M 37M 38M 37M 37M 36M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-03-05 2024-02-23 2023-02-23 2022-02-28 2021-02-25
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome -138 000 -8M -14M -7M -3M
ebit -725 000 111M 267M 145M 16M
nonOperatingIncomeExcludingInterest -16M 2M 2M -6M -25M
netIncomeFromContinuingOperations -15M 73M 186M 132M -12M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome -15M 73M 186M 132M -13M
epsDiluted -0.44 2.05 5.02 3.53 -0.34

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol CCRN CCRN CCRN CCRN CCRN CCRN CCRN CCRN CCRN CCRN CCRN CCRN CCRN CCRN
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-12 2025-08-06 2024-11-07 2024-08-01 2024-05-02 2023-11-02 2023-08-03 2023-05-04 2022-11-03
acceptedDate 2025-11-12 17:06:35 2025-08-06 16:45:15 2025-03-05 16:45:30 2024-11-07 15:59:06 2024-08-01 10:15:54 2024-05-02 07:12:10 2024-02-22 18:05:52 2023-11-02 09:41:38 2023-08-03 08:48:36 2023-05-04 09:02:53 2023-02-23 16:42:22 2022-11-03 11:11:20 2022-02-28 16:43:04 2021-02-25 16:17:22
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 99M 81M 82M 64M 70M 5M 17M 14M 673 000 291 000 4M 30M 1M 2M
shortTermInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
cashAndShortTermInvestments 99M 81M 82M 64M 70M 5M 17M 14M 673 000 291 000 4M 30M 1M 2M
netReceivables 190M 218M 243M 245M 260M 373M 388M 423M 497M 636M 660M 617M 499M 175M
inventory 0 0 0 0 1 1 0 5M 7M 11M 11M 0 0 0
otherCurrentAssets 6M 9M 3M 28M 8M 9M 2M 3M 1M 1M 1M 13M 638 000 1M
totalCurrentAssets 295M 309M 335M 337M 338M 387M 415M 445M 506M 649M 676M 660M 508M 183M
propertyPlantEquipmentNet 30M 30M 31M 32M 32M 30M 30M 29M 27M 26M 23M 22M 23M 23M
goodwill 135M 135M 135M 135M 135M 135M 135M 135M 137M 142M 163M 113M 119M 91M
intangibleAssets 48M 50M 42M 46M 49M 52M 54M 57M 60M 63M 45M 47M 48M 41M
goodwillAndIntangibleAssets 183M 185M 177M 182M 184M 187M 190M 193M 197M 205M 208M 160M 168M 132M
longTermInvestments 15M 16M 0 0 23M 23M 33 000 22M 22M 0 24M 0 15M 0
taxAssets 9M 8M 8M 9M 10M 7M 6M 7M 8M 8M 7M 9M 12M 0
otherNonCurrentAssets 5M 5M 38M 38M 16M 14M 38M 12M 12M 34M 10M 32M 7M 19M
totalNonCurrentAssets 243M 245M 254M 261M 265M 261M 264M 263M 265M 272M 272M 222M 225M 174M
otherAssets 0 0 0 0 0 1 0 0 0 0 0 0 0 0
totalAssets 538M 554M 589M 597M 603M 648M 679M 708M 771M 921M 948M 883M 733M 357M
accountPayables 42M 49M 6M 0 56M 69M 3M 115M 140M 177M 13M 192M 110M 50M
shortTermDebt 846 000 1M 0 2M 4M 2M 0 3M 3M 4M 0 4M 8M 2M
taxPayables 0 0 25M 10M 0 0 27M 0 0 0 20 000 19 000 7M 13M
deferredRevenue 0 0 0 0 1 0 0 57M 56M 0 0 0 0 0
otherCurrentLiabilities 42M 46M 29M 108M 50M 57M 127M 9M 17M 84M 155M 80M 9M 13M
totalCurrentLiabilities 86M 96M 120M 121M 110M 128M 149M 184M 216M 265M 272M 277M 200M 93M
longTermDebt 1M 1M 0 2M 3M 2M 0 3M 34M 142M 149M 135M 176M 56M
deferredRevenueNonCurrent 0 0 0 0 0 0 0 -10M 23M 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 0 0 566 000 0 0 0 401 000 10M 9M 0 247 000 237 000 190 000 7M
otherNonCurrentLiabilities 43M 44M 48M 50M 51M 50M 54M 51M 18M 61M 65M -14M 48M 31M
totalNonCurrentLiabilities 45M 45M 50M 52M 54M 52M 57M 55M 85M 204M 219M 183M 236M 109M
otherLiabilities 0 0 0 0 0 1 0 0 0 0 0 0 0 0
capitalLeaseObligations 1M 1M 4M 4M 5M 2M 5M 6M 6M 7M 9M 10M 11M 20M
totalLiabilities 130M 142M 170M 173M 164M 180M 206M 238M 301M 469M 491M 460M 435M 202M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 0 0
commonStock 3000 3000 3000 3000 3000 4000 4000 4000 4000 4000 4000 4000 4000 4000
retainedEarnings 206M 211M 218M 222M 225M 241M 238M 229M 217M 195M 166M 127M -23M -155M
accumulatedOtherComprehensiveIncomeLoss -2M -1M -1M -1M -1M -1M -1M -1M -1M -1M -1M -1M -1M -1M
othertotalStockholdersEquity 204M 203M 204M 215M 229M 242M 255M 258M 297M
totalStockholdersEquity 408M 412M 419M 425M 439M 468M 473M 470M 470M 452M 457M 423M 298M 154M
totalEquity 408M 412M 419M 425M 439M 468M 473M 470M 470M 452M 457M 423M 298M 155M
totalLiabilitiesAndStockholdersEquity 538M 554M 597M 603M 648M 708M 771M 921M 883M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 534 000
totalLiabilitiesAndTotalEquity 538M 554M 589M 597M 603M 648M 679M 708M 771M 921M 948M 883M 733M 357M
totalInvestments 15M 16M 0 0 23M 23M 33 000 22M 22M 0 24M 0 15M 0
totalDebt 2M 3M 4M 4M 5M 4M 5M 6M 37M 146M 158M 140M 195M 78M
netDebt -97M -78M -78M -60M -65M -750 000 -12M -8M 37M 146M 154M 109M 194M 76M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-03-05 2024-02-23 2023-02-23 2022-02-28 2021-02-25
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 223M 372M 642M 494M 170M
otherReceivables 20M 16M 18M 5M 5M
prepaids 8M 8M 0 8M 5M
totalPayables 68M 3M 13M 117M 63M
otherPayables 62M 0 0 7M 13M
accruedExpenses 21M 16M 100M 66M 11M
capitalLeaseObligationsCurrent 2M 3M 4M 0 5M
capitalLeaseObligationsNonCurrent 2M 3M 5M 11M 15M
treasuryStock 0 0 0 0 0
additionalPaidInCapital 202M 236M 293M 322M 310M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol CCRN CCRN CCRN CCRN CCRN CCRN CCRN CCRN CCRN CCRN CCRN CCRN CCRN CCRN
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-12 2025-08-06 2024-11-07 2024-08-01 2024-05-02 2023-11-02 2023-08-03 2023-05-04 2022-11-03
acceptedDate 2025-11-12 17:06:35 2025-08-06 16:45:15 2025-03-05 16:45:30 2024-11-07 15:59:06 2024-08-01 10:15:54 2024-05-02 07:12:10 2024-02-22 18:05:52 2023-11-02 09:41:38 2023-08-03 08:48:36 2023-05-04 09:02:53 2023-02-23 16:42:22 2022-11-03 11:11:20 2022-02-28 16:43:04 2021-02-25 16:17:22
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome -5M -7M -15M 3M -16M 3M 73M 134 000 21M 29M 186M 35M 132M -12M
depreciationAndAmortization 4M 4M 18M 4M 5M 5M 18M 5M 4M 5M 13M 3M 10M 13M
deferredIncomeTax -1M 623 000 -2M 1M -3M -809 000 1M 1M 107 000 -597 000 5M -679 000 -10M -932 000
stockBasedCompensation 766 000 870 000 6M 870 000 2M 1M 7M 1M 2M 2M 7M 1M 7M 5M
changeInWorkingCapital 22M 5M 88M -71M 75M -4M 127M 46M 85M -4M -104M 94M -237M -3M
accountsReceivables 22M 18M 128M -110M 96M 14M 251M 71M 139M 8M -153M 88M -318M -5M
inventory 0 0 0 0 0 0 0 23M 0 0 0 0 -83M -7M
accountsPayables -3M 0 -30M 33M -18M -15M -127M -23M 0 -12M 0 0 83M 7M
otherWorkingCapital 3M -13M -11M 5M -3M -2M 3M -25M -54M 4M 50M 6M 81M 2M
otherNonCashItems -508 000 256 000 25M 70M -47M 14M 22M 17M 7M 15M 27M 7M 13M 25M
netCashProvidedByOperatingActivities 20M 4M 120M 7M 82M 6M 248M 70M 119M 47M 134M 141M -86M 27M
investmentsInPropertyPlantAndEquipment -2M -2M -9M 5M -3M -2M -14M -3M -4M -4M -9M -3M -7M -5M
acquisitionsNet 0 0 0 0 0 0 199 000 -182 000 0 182 000 -35M 0 -27M -1M
purchasesOfInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
salesMaturitiesOfInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherInvestingActivites 0 0 -6M -3M -2M 199 000 0 0 0
netCashUsedForInvestingActivites -2M -2M -1M -3M -2M -3M -4M -3M -3M
debtRepayment 0 0 0 0 -14M -143M -315M -358M -451M
commonStockIssued 0 0 0 0 0 0 0 0 0
commonStockRepurchased 0 0 -37M -12M -15M -6M -58M -15M -5M -32M -35M 0 -2M -658 000
dividendsPaid 0 0 0 0 0 0 0 0 0
otherFinancingActivites -6000 -2M -6000 -248 000 -9M 104M 205M 343M 344M
netCashUsedProvidedByFinancingActivities -6000 -2M -12M -15M -16M -53M -115M -47M -108M
effectOfForexChangesOnCash 22 000 2000 -14 000 0 0 0 8000 -2000 1000 -1000 -9000 -10000 6000 -11 000
netChangeInCash 18M 496 000 65M -6M 64M -12M 13M 14M 382 000 -3M 3M 30M -564 000 568 000
cashAtEndOfPeriod 99M 81M 82M 64M 70M 5M 17M 14M 673 000 291 000 4M 30M 1M 2M
cashAtBeginningOfPeriod 81M 81M 17M 70M 5M 17M 4M 673 000 291 000 4M 1M 279 000 2M 1M
operatingCashFlow 20M 4M 120M 7M 82M 6M 248M 70M 119M 47M 134M 141M -86M 27M
capitalExpenditure -2M -2M -9M -1M -3M -2M -14M -3M -4M -4M -9M -3M -7M -5M
freeCashFlow 18M 2M 111M 6M 80M 4M 235M 67M 115M 43M 125M 138M -93M 23M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-03-05 2024-02-23 2023-02-23 2022-02-28 2021-02-25
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities 0 0 0 0 1M
netCashProvidedByInvestingActivities -9M -14M -44M -34M -5M
netDebtIssuance 0 -151M 32M 128M -20M
longTermNetDebtIssuance 0 -151M -35M 172M -20M
shortTermNetDebtIssuance 0 0 68M -44M -81 000
netStockIssuance -37M -58M -35M -2M -658 000
netCommonStockIssuance -37M -58M -35M -2M -658 000
commonStockIssuance 0 0 0 0 0
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities -10M -13M -85M -6M -1M
netCashProvidedByFinancingActivities -47M -221M -88M 119M -22M
incomeTaxesPaid 2M 22M 83M 4M 612 000
interestPaid 0 8M 13M 6M 3M

Earning call transcript

2024 q3
2024-11-06 ET (fiscal 2024 q3)
2024 q2
2024-07-31 ET (fiscal 2024 q2)
2024 q1
2024-05-01 ET (fiscal 2024 q1)
2023 q4
2024-02-21 ET (fiscal 2023 q4)
2023 q3
2023-11-01 ET (fiscal 2023 q3)
2023 q2
2023-08-02 ET (fiscal 2023 q2)
2023 q1
2023-05-03 ET (fiscal 2023 q1)
2022 q4
2023-02-22 ET (fiscal 2022 q4)
2022 q3
2022-11-03 ET (fiscal 2022 q3)
2022 q2
2022-08-03 ET (fiscal 2022 q2)
2022 q1
2022-05-04 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 10
2025-11-12 17:06 ET
Cross Country Healthcare reported for 2025 q3
SEC form 8
2025-11-12 17:03 ET
Cross Country Healthcare published news for 2025 q3
SEC form 8
2025-11-12 17:03 ET
Cross Country Healthcare published news for 2025 q3
SEC form 10
2025-08-06 20:45 ET
Cross Country Healthcare reported for 2025 q2
SEC form 8
2025-08-06 20:27 ET
Cross Country Healthcare published news for 2025 q2
SEC form 8
2025-08-06 20:27 ET
Cross Country Healthcare published news for 2025 q2
SEC form 10
2025-05-07 20:45 ET
Cross Country Healthcare reported for 2025 q1
SEC form 8
2025-05-07 20:28 ET
Cross Country Healthcare published news for 2025 q1
SEC form 8
2025-05-07 20:28 ET
Cross Country Healthcare published news for 2025 q1
SEC form 10
2025-05-07 00:00 ET
Cross Country Healthcare published news for 2025 q1
SEC form 10
2025-03-05 16:45 ET
Cross Country Healthcare reported for 2024 q4
SEC form 8
2025-03-05 16:25 ET
Cross Country Healthcare published news for 2024 q4
SEC form 8
2025-03-05 16:25 ET
Cross Country Healthcare published news for 2024 q4
SEC form 10
2025-03-05 00:00 ET
Cross Country Healthcare published news for 2024 q4
SEC form 8
2025-02-28 21:54 ET
Cross Country Healthcare published news for 2024 q4
SEC form 8
2025-02-28 21:54 ET
Cross Country Healthcare published news for 2024 q4
SEC form 10
2024-11-07 15:59 ET
Cross Country Healthcare reported for 2024 q3
SEC form 8
2024-11-06 16:28 ET
Cross Country Healthcare published news for 2024 q3
SEC form 8
2024-11-06 16:28 ET
Cross Country Healthcare published news for 2024 q3
SEC form 10
2024-08-01 10:15 ET
Cross Country Healthcare reported for 2024 q2
SEC form 10
2024-08-01 00:00 ET
Cross Country Healthcare published news for 2024 q2
SEC form 8
2024-07-31 16:26 ET
Cross Country Healthcare published news for 2024 q2
SEC form 8
2024-07-31 16:26 ET
Cross Country Healthcare reported for 2024 q2
SEC form 10
2024-05-02 07:12 ET
Cross Country Healthcare published news for 2024 q1
SEC form 10
2024-05-02 00:00 ET
Cross Country Healthcare published news for 2024 q1
SEC form 8
2024-05-01 16:27 ET
Cross Country Healthcare published news for 2024 q1
SEC form 8
2024-05-01 16:27 ET
Cross Country Healthcare reported for 2024 q1
SEC form 10
2024-02-23 00:00 ET
Cross Country Healthcare reported for 2023 q4
SEC form 8
2024-02-21 16:24 ET
Cross Country Healthcare published news for 2023 q4
SEC form 8
2024-02-21 16:24 ET
Cross Country Healthcare reported for 2023 q4
SEC form 10
2023-11-02 09:41 ET
Cross Country Healthcare reported for 2023 q3
SEC form 10
2023-11-02 00:00 ET
Cross Country Healthcare published news for 2023 q3
SEC form 8
2023-11-01 16:30 ET
Cross Country Healthcare reported for 2023 q3
SEC form 10
2023-08-03 08:48 ET
Cross Country Healthcare reported for 2023 q2
SEC form 10
2023-08-03 00:00 ET
Cross Country Healthcare published news for 2023 q2
SEC form 6
2023-08-02 16:31 ET
Cross Country Healthcare reported for 2023 q2
SEC form 8
2023-08-02 00:00 ET
Cross Country Healthcare reported for 2023 q2
SEC form 6
2023-07-11 16:30 ET
Cross Country Healthcare published news for 2023 q2
SEC form 10
2023-05-04 00:00 ET
Cross Country Healthcare published news for 2023 q1
SEC form 8
2023-05-03 00:00 ET
Cross Country Healthcare published news for 2023 q1
SEC form 6
2023-04-18 16:45 ET
Cross Country Healthcare published news for 2023 q1
SEC form 6
2023-04-17 16:44 ET
Cross Country Healthcare published news for 2023 q1
SEC form 6
2023-04-10 16:35 ET
Cross Country Healthcare published news for 2023 q1
SEC form 10
2023-02-23 16:42 ET
Cross Country Healthcare published news for 2022 q4
SEC form 10
2023-02-23 00:00 ET
Cross Country Healthcare reported for 2022 q4
SEC form 6
2023-02-22 16:31 ET
Cross Country Healthcare published news for 2022 q4
SEC form 8
2023-02-22 00:00 ET
Cross Country Healthcare reported for 2022 q4
SEC form 6
2023-02-13 16:30 ET
Cross Country Healthcare published news for 2022 q4
SEC form 6
2023-01-31 16:31 ET
Cross Country Healthcare published news for 2022 q4
SEC form 6
2023-01-05 06:30 ET
Cross Country Healthcare published news for 2022 q4
SEC form 6
2022-12-16 16:30 ET
Cross Country Healthcare published news for 2022 q3
SEC form 6
2022-11-21 17:32 ET
Cross Country Healthcare published news for 2022 q3
SEC form 6
2022-11-17 16:31 ET
Cross Country Healthcare published news for 2022 q3
SEC form 6
2022-11-09 16:31 ET
Cross Country Healthcare published news for 2022 q3
SEC form 10
2022-11-03 11:11 ET
Cross Country Healthcare published news for 2022 q3
SEC form 10
2022-11-03 00:00 ET
Cross Country Healthcare reported for 2022 q3
SEC form 6
2022-11-02 16:30 ET
Cross Country Healthcare published news for 2022 q3
SEC form 8
2022-11-02 00:00 ET
Cross Country Healthcare reported for 2022 q3
SEC form 6
2022-10-13 16:30 ET
Cross Country Healthcare published news for 2022 q3
SEC form 6
2022-10-11 06:05 ET
Cross Country Healthcare published news for 2022 q3
SEC form 6
2022-09-19 16:40 ET
Cross Country Healthcare published news for 2022 q2
SEC form 6
2022-09-14 09:46 ET
Cross Country Healthcare published news for 2022 q2
SEC form 8
2022-09-14 00:00 ET
Cross Country Healthcare published news for 2022 q2
SEC form 6
2022-08-17 13:30 ET
Cross Country Healthcare published news for 2022 q2
SEC form 6
2022-08-16 16:48 ET
Cross Country Healthcare published news for 2022 q2
SEC form 6
2022-08-15 17:10 ET
Cross Country Healthcare published news for 2022 q2
SEC form 10
2022-08-04 09:33 ET
Cross Country Healthcare published news for 2022 q2
SEC form 10
2022-08-04 00:00 ET
Cross Country Healthcare reported for 2022 q2
SEC form 6
2022-08-03 16:31 ET
Cross Country Healthcare published news for 2022 q2
SEC form 8
2022-08-03 00:00 ET
Cross Country Healthcare reported for 2022 q2
SEC form 6
2022-07-11 16:30 ET
Cross Country Healthcare published news for 2022 q2
SEC form 6
2022-05-18 15:00 ET
Cross Country Healthcare published news for 2022 q1
SEC form 6
2022-05-13 16:31 ET
Cross Country Healthcare published news for 2022 q1
SEC form 10
2022-05-05 09:27 ET
Cross Country Healthcare published news for 2022 q1
SEC form 10
2022-05-05 00:00 ET
Cross Country Healthcare reported for 2022 q1
SEC form 6
2022-05-04 16:32 ET
Cross Country Healthcare published news for 2022 q1
SEC form 8
2022-05-04 00:00 ET
Cross Country Healthcare reported for 2022 q1
SEC form 6
2022-04-18 16:31 ET
Cross Country Healthcare published news for 2022 q1
SEC form 6
2022-04-12 16:31 ET
Cross Country Healthcare published news for 2022 q1
SEC form 6
2022-04-07 08:45 ET
Cross Country Healthcare published news for 2022 q1
SEC form 6
2022-04-04 08:04 ET
Cross Country Healthcare published news for 2022 q1
SEC form 6
2022-03-22 16:45 ET
Cross Country Healthcare published news for 2021 q4
SEC form 10
2022-02-28 16:43 ET
Cross Country Healthcare published news for 2021 q4
SEC form 10
2022-02-28 00:00 ET
Cross Country Healthcare published news for 2021 q4
SEC form 6
2022-02-23 16:33 ET
Cross Country Healthcare published news for 2021 q4
SEC form 8
2022-02-23 00:00 ET
Cross Country Healthcare published news for 2021 q4
SEC form 6
2022-02-17 16:16 ET
Cross Country Healthcare published news for 2021 q4
SEC form 6
2022-01-31 16:20 ET
Cross Country Healthcare published news for 2021 q4
SEC form 6
2022-01-19 08:50 ET
Cross Country Healthcare published news for 2021 q4
SEC form 8
2022-01-19 00:00 ET
Cross Country Healthcare published news for 2021 q4
SEC form 6
2021-12-16 16:31 ET
Cross Country Healthcare published news for 2021 q3
SEC form 6
2021-11-19 14:31 ET
Cross Country Healthcare published news for 2021 q3
SEC form 6
2021-11-12 09:18 ET
Cross Country Healthcare published news for 2021 q3
SEC form 10
2021-11-04 11:22 ET
Cross Country Healthcare published news for 2021 q3
SEC form 10
2021-11-04 00:00 ET
Cross Country Healthcare published news for 2021 q3
SEC form 6
2021-11-03 16:32 ET
Cross Country Healthcare published news for 2021 q3
SEC form 8
2021-11-03 00:00 ET
Cross Country Healthcare published news for 2021 q3
SEC form 6
2021-10-15 11:15 ET
Cross Country Healthcare published news for 2021 q3
SEC form 6
2021-10-07 16:16 ET
Cross Country Healthcare published news for 2021 q3
SEC form 6
2021-08-16 16:16 ET
Cross Country Healthcare published news for 2021 q2
SEC form 10
2021-08-05 11:55 ET
Cross Country Healthcare published news for 2021 q2
SEC form 10
2021-08-05 00:00 ET
Cross Country Healthcare published news for 2021 q2
SEC form 6
2021-08-04 16:31 ET
Cross Country Healthcare published news for 2021 q2
SEC form 8
2021-08-04 00:00 ET
Cross Country Healthcare published news for 2021 q2
SEC form 6
2021-07-30 15:52 ET
Cross Country Healthcare published news for 2021 q2
SEC form 6
2021-07-14 16:15 ET
Cross Country Healthcare published news for 2021 q2
SEC form 6
2021-06-14 16:55 ET
Cross Country Healthcare published news for 2021 q1
SEC form 6
2021-06-09 17:31 ET
Cross Country Healthcare published news for 2021 q1
SEC form 6
2021-06-08 18:52 ET
Cross Country Healthcare published news for 2021 q1
SEC form 6
2021-05-17 15:30 ET
Cross Country Healthcare published news for 2021 q1
SEC form 6
2021-05-14 15:45 ET
Cross Country Healthcare published news for 2021 q1
SEC form 6
2021-05-10 16:30 ET
Cross Country Healthcare published news for 2021 q1
SEC form 10
2021-05-06 11:04 ET
Cross Country Healthcare published news for 2021 q1
SEC form 10
2021-05-06 00:00 ET
Cross Country Healthcare published news for 2021 q1
SEC form 6
2021-05-05 16:30 ET
Cross Country Healthcare published news for 2021 q1
SEC form 8
2021-05-05 00:00 ET
Cross Country Healthcare published news for 2021 q1
SEC form 6
2021-04-20 16:16 ET
Cross Country Healthcare published news for 2021 q1
SEC form 6
2021-04-14 16:17 ET
Cross Country Healthcare published news for 2021 q1
SEC form 6
2021-03-31 16:39 ET
Cross Country Healthcare published news for 2020 q4
SEC form 6
2021-03-31 10:14 ET
Cross Country Healthcare published news for 2020 q4
SEC form 6
2021-03-30 09:12 ET
Cross Country Healthcare published news for 2020 q4
SEC form 6
2021-03-10 08:05 ET
Cross Country Healthcare published news for 2020 q4
SEC form 10
2021-02-25 16:17 ET
Cross Country Healthcare published news for 2020 q4
SEC form 6
2021-02-24 16:31 ET
Cross Country Healthcare published news for 2020 q4
SEC form 6
2021-02-22 12:15 ET
Cross Country Healthcare published news for 2020 q4
SEC form 6
2021-02-16 14:17 ET
Cross Country Healthcare published news for 2020 q4
SEC form 6
2021-01-29 16:31 ET
Cross Country Healthcare published news for 2020 q4
SEC form 6
2021-01-25 18:19 ET
Cross Country Healthcare published news for 2020 q4
SEC form 10
2020-11-05 11:36 ET
Cross Country Healthcare published news for 2020 q3
SEC form 6
2020-11-04 16:16 ET
Cross Country Healthcare published news for 2020 q3
SEC form 6
2020-10-21 13:23 ET
Cross Country Healthcare published news for 2020 q3
SEC form 6
2020-10-20 14:03 ET
Cross Country Healthcare published news for 2020 q3